Back to search
Lupus Nephritis - WHO Class III
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lupus Nephritis - WHO Class III trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Lupus Nephritis - WHO Class III trials you may qualify forThe primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following…
AB-101 (also known as AlloNK) is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of t…